P. Demoerloose et al., NEONATAL THROMBOCYTOPENIA - INCIDENCE AND CHARACTERIZATION OF MATERNAL ANTIPLATELET ANTIBODIES BY MAIPA ASSAY, British Journal of Haematology, 100(4), 1998, pp. 735-740
Neonatal thrombocytopenia (NNT) which is frequent in distressed newbor
ns was uncommon in a nonselected population of neonates, The aim of th
is prospective study was to determine the frequency of NNT and, in con
firmed NNT, to search for maternal antiplatelet antibodies with a mono
clonal antibody-specific immobilization of platelet antigens (MAIPA) a
ssay, Among the 8388 newborns studied, 40 (0.5%, 95% CI 0.3-0.6) had c
onfirmed NNT, which was severe (platelet count < 50 x 10(9)/l) in 10 c
ases (0.12%, 95% CL 0.05-0.20). Antiplatelet antibodies were detected
in 10/31 studied mothers of thrombocytopenic newborns (32.3%): they we
re alloantibodies in five cases and autoantibodies in five other cases
, Among these 10 newborns, seven had severe thrombocytopenia and four
had bleeding complications. As controls, antiplatelet antibodies were
also searched for in mothers of non-thrombocytopenic newborns: antipla
telet antibodies were present in 8.5% (95% CI 5.9-11.7) of thrombocyto
penic mothers (n = 400) and 3.2% (95% CI 0.7-9.0) of non-thrombocytope
nic mothers (n = 95). The difference was significant between the contr
ol groups and the group of mothers of thrombocytopenic newborns. In co
nclusion, our data indicate that an immune origin is frequent in NNT a
nd should be looked for, particularly when the platelet count is < 50
x 10(9)/l.